United States
Print page content Print
Increase text size Decrease text size
Text Size

DORMOSEDAN GEL® (detomidine hydrochloride) is administered under the tongue and the dosing syringe delivers the product in 0.25-mL increments. The dosing syringe is intended for one-time use and then should be properly discarded. The dosing table, shown below, provides the dose volume to be administered for the corresponding body weight in 0.25-mL increments.

BODY WEIGHT (lb) DOSE VOLUME (mL)
330-439 1.00
440-549 1.25
550-659 1.50
660-769 1.75
770-879 2.00
880-989 2.25
990-1,099 2.50
1,100-1,209 2.75
1,210-1,320 3.00

The horse should be kept in a quiet, comfortable environment before, during and after treatment. It is important to withhold food and water until the sedative effects have worn off.

ONSET AND DURATION OF SEDATION
The duration and level of sedation are dose dependent. At the recommended 0.018 mg/lb (0.040 mg/kg) dose, the onset of sedation was observed at approximately 40 minutes with a duration of sedation lasting between 90 to 180 minutes.

IMPORTANT SAFETY INFORMATION
Do not use DORMOSEDAN GEL in horses with pre-existing atrioventricular (AV) or sinoatrial (SA) block, with severe coronary insufficiency, cerebrovascular disease, respiratory disease, or chronic renal failure. Do not use in anesthetized or sedated horses, or in conditions of shock, severe debilitation or stress due to extreme heat, cold, fatigue or high altitude. Do not use in horses intended for human consumption. Handle gel-dosing syringes with caution to avoid direct exposure to skin, eyes or mouth. See full Prescribing Information.

DOR-00069